VINESSA GAERLAN-FINCH: Open Payments
NPI 1275729329 · LAGUNA NIGUEL, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,665 in 68 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,059 · 2025 $1,665
Food & beverage: $1,665
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 9 | $380 |
| Otsuka America Pharmaceutical, Inc. | 14 | $318 |
| Neos Therapeutics, LP | 10 | $145 |
| Tris Pharma Inc | 6 | $138 |
| Lundbeck LLC | 5 | $135 |
| Neurocrine BioSciences, Inc. | 5 | $124 |
| Indivior Inc. | 3 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $63 |
| ABBVIE INC. | 3 | $62 |
| Alkermes, Inc. | 2 | $48 |
Products named: REXULTI, FANAPT, HETLIOZ, Dyanavel XR, Adzenys XR-ODT, INGREZZA, SUBLOCADE, CAPLYTA.
Industry payments across CA — which companies pay providers there.
